Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Cullinan Therapeutics Inc’s current trading price is -24.05% away from its 52-week high, while its distance from the 52-week low is 104.97%. The stock’s price range during this period has varied between $7.64 and $20.62. The company, active in the Healthcare sector, saw a trading volume of around 1.18 million for the day, considerably higher average daily volume of 0.5 million observed over the last three months.
Cullinan Therapeutics Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $20.62 on 04/16/24, while the lowest price during the same period was $7.64 on 12/12/23.
How Financial Performance Impacts Market Capitalization
Cullinan Therapeutics Inc (CGEM) has experienced a quarterly rise of 36.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 674.48M and boasts a workforce of 85 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 14.10, with a change in price of +6.90. Similarly, Cullinan Therapeutics Inc recorded 415,378 in trading volume during the last 100 days, posting a change of +78.77%.
How CGEM’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CGEM stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
CGEM Stock Stochastic Average
As of today, the raw stochastic average of Cullinan Therapeutics Inc over the last 50 days is at 12.06%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 8.49%. Further, the company’s Stochastic %K and %D values for the last 20 days were 35.37% and 43.11%, respectively.
CGEM Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 53.68%. However, over the past six months, we’ve seen a weaker performance of 73.23%. The price of CGEM fallen by 0.84% over the last 30 days. And in the last five days, it has fallen by -6.06%.
